Bänziger, Silas http://orcid.org/0000-0002-3342-8914
Weisshaar, Kimmo http://orcid.org/0000-0001-9566-2346
Arokoski, Reetta
Gerull, Sabine http://orcid.org/0000-0002-6612-4220
Halter, Jörg http://orcid.org/0000-0003-4304-1956
Rovó, Alicia http://orcid.org/0000-0002-7757-4753
Bargetzi, Mario http://orcid.org/0000-0002-2519-6754
Goede, Jeroen S. http://orcid.org/0000-0001-7054-0174
Senft, Yuliya
Valenta, Sabine http://orcid.org/0000-0002-5598-9579
Passweg, Jakob R. http://orcid.org/0000-0001-7092-3351
Drexler, Beatrice http://orcid.org/0000-0002-7046-0825
Funding for this research was provided by:
Universität Basel
ProPatient Foundation
Kaiku Health Ltd.
Novartis
University of Basel
Article History
Received: 24 May 2022
Accepted: 12 October 2022
First Online: 3 November 2022
Declarations
:
: The study was approved by the local ethics committee (EKNZ Nr. 2019–01563) and registered under ClinicalTrials.gov (NCT04128943). All parts of the study were performed within the principles of the Declaration of Helsinki. Informed consent was obtained from all patients for being included in the study.
: RA is an employee of Kaiku Health Ltd. The other authors declare no competing interests.